Seventure Partners is a leading European venture capital firm founded in 1997 and headquartered in Paris, France. It invests in innovative companies across life sciences (microbiome, health, nutrition, foodtech, biotech) and digital technologies (fintech, retailtech), from seed to growth stage.
34% of their portfolio is in Biotech & Life Sciences. Average disclosed round size is $27.1M (across 64 rounds with reported amounts).
Portfolio
82
Fund Size
—
Top Stage
Series A
Last 12 Mo
7
Team
Emmanuel Fiessinger
Senior Partner in the Lifesciences team
Pierre Aumeunier
Chief Financial Officer
Iain Wilcock
UK Venture Partner
Oxana Kukhaneva
Venture Partner
Thibault Canton
Partner
Jeanne Berron
Life Sciences Investment Associate
Quang Lê
Analyst
Guillaume Echaudemaison
Tech VC
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
 Hackuity | Series A | — | Sep 2026 |
 Wultra | Series A | — | Jul 2026 |
 Standing Ovation | Series B | $28.5M | Mar 2026 |
 ErVimmune | Series A | $19.8M | Jan 2026 |
| TThe Sanctuary Group | Unknown | $5.8M | Jan 2026 |
| Hackuity | Series B | $19M | Jan 2026 |
| Standing Ovation | Series A | $34.2M | Jan 2026 |
| VVertero | Series D | $20M | Oct 2025 |
 Tubulis | Series C | — | Oct 2025 |
| TTubulis GmbH | Series C | — | Oct 2025 |
 Animab | Series B | — | Jul 2025 |
 Sekoia | Series B | — | Apr 2025 |
| FFlexvelop | Growth | — | Mar 2025 |
 Karmen | Unknown | $9.4M | Jan 2025 |
| Animab | Series B | — | Jan 2025 |
 FIRE1 | Unknown | $120M | Jan 2025 |
 bsport | Series B | — | Dec 2024 |
 Citryll | Series B | — | Dec 2024 |
| SSyroco | Series A | — | Dec 2024 |
 AENITIS TECHNOLOGIES | Unknown | — | Oct 2024 |
 Allozymes | Series A | $15M | May 2024 |
 Peptobiotics | Series A | $6.2M | Jan 2024 |
 YesWeHack | Series C | — | Jan 2024 |
| CComet Meetings | Series A | — | Jan 2024 |
 Vedanta Biosciences | Series D | $40M | Jan 2024 |
Top Co-Investors
Last updated: 20 October 2026